A Rochester biotech firm named Vyriad is launching a $9 million project to build a manufacturing unit at the former IBM campus in northwest Rochester.
Vyriad has leased space inside the new Rochester Technology Campus.
The company plans to manufacture clinical-stage oncolytic virus therapies to use fighting cancer.
With the support of Mayo Clinic, Vyriad President and CEO Stephen Russell says his firm is "taking a giant leap forward" to deliver its unique anti-cancer virus therapies to patients.
The buildout should be done by the end of this year.
6301 Bandel Road NW, Rochester, MN 55901
Switchboard: 507-252-4747 or 1-877-369-4788
News tips: 507-281-4747 or email@example.com